Publications
Driving clinical research and progress of neurotransformational therapeutics
Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin
Emmanuelle A. D. Schindler1,2,3 & R. Andrew Sewell4,5 & Christopher H. Gottschalk3 & Christina Luddy4,5 &L. Taylor Flynn4,5 & Hayley Lindsey1,2,3 & Brian P. Pittman4 & Nicholas V. Cozzi6,7 & Deepak C. D’Souza4,5 . October 27, 2020
Psychoactive Substances as a Last Resort—a Qualitative Study of Self-Treatment of Migraine and Cluster Headaches
Martin Andersson, Mari Persson & Anette Kjellgren. Harm Reduction Journal volume 14, Article number: 60 (2017)
Indoleamine Hallucinogens in Cluster Headache: Results of the Clusterbusters Medication Use Survey
Emmanuelle A. D. Schindler, M.D., Ph.D., Christopher H. Gottschalk , M.D., Marsha J. Weil, Robert E. Shapiro , M.D., Douglas A. Wright , D.C. & Richard Andrew Sewell , M.D. Journal of Psychoactive Drugs Volume 47, 2015 – Issue 5
Psilocybin and Obsessive Compulsive Disorder
James Allen Wilcox. J Psychoactive Drugs Nov-Dec 2014;46(5):393-5. doi:10.1080/02791072.2014.963754.
Serotonergic and Dopaminergic Distinctions in the Behavioral Pharmacology of(±)-1-(2,5-Dimethoxy-4-iodophenyl)-2-Aminopropane (DOI) and Lysergic Acid diethylamide (LSD)
Emmanuelle A.D. Schindler ⁎, Kuldip D. Dave, Elaine M. Smolock, Vincent J. Aloyo, John A. Harvey. Pharmacology, Biochemistry and Behavior 101 (2012) 69–76
The Non-Hallucinogen 2-Bromo-lysergic Acid Diethylamide as Preventative Treatment for Cluster Headache: An Open, Non-Randomized Case Series
Matthias Karst, John H, Halpern, Michael Bernateck, Torsten Passie. Cephalalgia. 2011 Apr; 31(5):634.
Response of Cluster Headache to Psilocybin and LSD
R. Andrew Sewell, MD; John H. Halpern, MD; and Harrison G. Pope, Jr., MD. Neurology June 27, 2006; 66(12)
Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder
Francisco A Moreno 1, Christopher B Wiegand, E Keolani Taitano, Pedro L Delgado J Clin Psychiatry. 2006 Nov;67(11):1735-40. doi: 10.4088/jcp.v67n1110.
Cholinesterase, Dlysergic Acid Diethylamide, and 2-Bromolysergic Acid Diethylamide
J R BERTINO, G D KLEE, W WEINTRAUB J Clin Exp Psychopathol Q Rev Psychiatry Neurol. Jul-Sep 1959;20:218-22.
Role of 5-Hydroxytryptamine in Mental Diseases and its Antagonism to Lysergic Acid Derivatives
A.CERLETTI & E. ROTHLIN Nature October 22, 1955